Thiothixene (BioDeep_00000018248)

   

human metabolite blood metabolite Chemicals and Drugs


代谢物信息卡片


(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]-9H-thioxanthene-2-sulfonamide

化学式: C23H29N3O2S2 (443.1701094)
中文名称: 替沃噻吨, 氨砜噻吨
谱图信息: 最多检出来源 Homo sapiens(blood) 7.14%

分子结构信息

SMILES: CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
InChI: InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-

描述信息

Thiothixene is only found in individuals that have used or taken this drug. It is a thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics. [PubChem]Thiothixene acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects).
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
(Z)-Thiothixene is an antagonist of serotonergic receptor extracted from patent US 20150141345 A1.

同义名列表

12 个代谢物同义名

(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]-9H-thioxanthene-2-sulfonamide; Pfizer brand OF tiotixene dihydrochloride; Pfizer brand OF tiotixene; Tiotixene pfizer brand; (e)-Thiothixene; (Z)-Thiothixene; cis-Thiothixene; Thiothixine; Thiothixene; Tiotixene; Orbinamon; Navane



数据库引用编号

13 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Matthew H Slawson, Kamisha L Johnson-Davis. Quantitation of Haloperidol, Fluphenazine, Perphenazine, and Thiothixene in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in molecular biology (Clifton, N.J.). 2016; 1383(?):49-57. doi: 10.1007/978-1-4939-3252-8_6. [PMID: 26660173]
  • JoEtta M Juenke, Paul I Brown, Francis M Urry, Kamisha L Johnson-Davis, Gwendolyn A McMillin. Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma. Clinica chimica acta; international journal of clinical chemistry. 2013 Aug; 423(?):32-4. doi: 10.1016/j.cca.2013.04.014. [PMID: 23618971]
  • Daniel J Warner, Hongming Chen, Louis-David Cantin, J Gerry Kenna, Simone Stahl, Clare L Walker, Tobias Noeske. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals. 2012 Dec; 40(12):2332-41. doi: 10.1124/dmd.112.047068. [PMID: 22961681]
  • Ann E Maloney, Linmarie Sikich. Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients. Neuropsychiatric disease and treatment. 2010 Nov; 6(?):749-66. doi: 10.2147/ndt.s6614. [PMID: 21127693]
  • R Miller. Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II. Current neuropharmacology. 2009 Dec; 7(4):315-30. doi: 10.2174/157015909790031184. [PMID: 20514211]
  • Tomiki Sumiyoshi, Karu Jayathilake, Herbert Y Meltzer. A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia. Schizophrenia research. 2003 Jul; 62(1-2):65-72. doi: 10.1016/s0920-9964(02)00351-1. [PMID: 12765745]
  • Aron D Mosnaim, Javier Puente, Rolando Saavedra, Seymour Diamond, Marion E Wolf. In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure. Pharmacology. 2003 Jan; 67(1):6-13. doi: 10.1159/000066781. [PMID: 12444298]
  • F A Aly, S A al-Tamimi, A A Alwarthan. Flow-injection chemiluminometric determination of some thioxanthene derivatives in pharmaceutical formulations and biological fluids using the [Ru(dipy)3(2+)]-Ce(IV) system. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry. 2001 Nov; 17(11):1257-61. doi: 10.2116/analsci.17.1257. [PMID: 11759505]
  • H D Desai, J Seabolt, M W Jann. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS drugs. 2001; 15(6):469-94. doi: 10.2165/00023210-200115060-00005. [PMID: 11524025]
  • J S Markowitz, B D Gaulin, M I Good. Significance of plasma thiothixene concentrations. The Annals of pharmacotherapy. 1995 Jul; 29(7-8):789-90. doi: 10.1177/106002809502907-829. [PMID: 8520104]
  • C A Peabody, M D Warner, M Griffin, N N Boutros, I G Worsley, H G Friesen. Prolactin bioassay in schizophrenia before and after neuroleptics. Psychiatry research. 1992 Mar; 41(3):249-55. doi: 10.1016/0165-1781(92)90006-o. [PMID: 1594711]
  • L Ereshefsky, S R Saklad, M D Watanabe, C M Davis, M W Jann. Thiothixene pharmacokinetic interactions: a study of hepatic enzyme inducers, clearance inhibitors, and demographic variables. Journal of clinical psychopharmacology. 1991 Oct; 11(5):296-301. doi: NULL. [PMID: 1765572]
  • M Hariharan, T VanNoord, E K Kindt, R Tandon. A simple, sensitive liquid chromatographic assay of cis-thiothixene in plasma with coulometric detection. Therapeutic drug monitoring. 1991 Jan; 13(1):79-85. doi: 10.1097/00007691-199101000-00012. [PMID: 1676194]
  • T Van Putten, S R Marder, W C Wirshing, M Aravagiri, N Chabert. Neuroleptic plasma levels. Schizophrenia bulletin. 1991; 17(2):197-216. doi: 10.1093/schbul/17.2.197. [PMID: 1679251]
  • L Bjerkenstedt. Melperone in the treatment of schizophrenia. Acta psychiatrica Scandinavica. Supplementum. 1989; 352(?):35-9. doi: 10.1111/j.1600-0447.1989.tb06434.x. [PMID: 2479227]
  • C Dilger, Z Salama, H Jaeger. Improved high-performance liquid chromatographic method for the determination of tiotixene in human serum. Arzneimittel-Forschung. 1988 Oct; 38(10):1522-5. doi: NULL. [PMID: 3196395]
  • C M Davis, C A Harrington. Quantitation of thiothixene in plasma by high-performance thin-layer chromatography and fluorometric detection. Therapeutic drug monitoring. 1988; 10(2):215-23. doi: 10.1097/00007691-198802000-00017. [PMID: 3381241]
  • J A Yesavage, E D Tanke, J I Sheikh. Tardive dyskinesia and steady-state serum levels of thiothixene. Archives of general psychiatry. 1987 Oct; 44(10):913-5. doi: 10.1001/archpsyc.1987.01800220085012. [PMID: 2889439]
  • L E Hollister, L Lombrozo, C C Huang. Plasma concentrations of thiothixene and clinical response in treatment-resistant schizophrenics. International clinical psychopharmacology. 1987 Jan; 2(1):77-82. doi: 10.1097/00004850-198701000-00007. [PMID: 3312399]
  • S G Dahl. Plasma level monitoring of antipsychotic drugs. Clinical utility. Clinical pharmacokinetics. 1986 Jan; 11(1):36-61. doi: 10.2165/00003088-198611010-00003. [PMID: 2868820]
  • G M Simpson, K Yadalam. Blood levels of neuroleptics: state of the art. The Journal of clinical psychiatry. 1985 May; 46(5 Pt 2):22-8. doi: NULL. [PMID: 2859277]
  • M Kemal, R H Imami. Acute thiothixene overdose. Journal of analytical toxicology. 1985 Mar; 9(2):94-5. doi: 10.1093/jat/9.2.94. [PMID: 3990255]
  • N Narasimhachari, R C Dorey, B L Landa, R O Friedel. Improved high-performance liquid chromatographic method for the quantitation of cis-thiothixene in plasma samples using trans-thiothixene as internal standard. Journal of chromatography. 1984 Nov; 311(2):424-9. doi: 10.1016/s0378-4347(00)84741-6. [PMID: 6520191]
  • M L Mavroidis, D R Kanter, J Hirschowitz, D L Garver. Clinical relevance of thiothixene plasma levels. Journal of clinical psychopharmacology. 1984 Jun; 4(3):155-7. doi: NULL. [PMID: 6736276]
  • R B Mailman, D L DeHaven, E A Halpern, M H Lewis. Serum effects confound the neuroleptic radioreceptor assay. Life sciences. 1984 Mar; 34(11):1057-64. doi: 10.1016/0024-3205(84)90019-5. [PMID: 6142394]
  • D Y Kim, L E Hollister. Drug-refractory chronic schizophrenics: doses and plasma concentrations of thiothixene. Journal of clinical psychopharmacology. 1984 Feb; 4(1):32-5. doi: NULL. [PMID: 6693581]
  • L T Kucharski, P Alexander, L Tune, J Coyle. Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients. Psychopharmacology. 1984; 82(3):194-8. doi: 10.1007/bf00427772. [PMID: 6144127]
  • J A Yesavage. Correlates of dangerous behavior by schizophrenics in hospital. Journal of psychiatric research. 1984; 18(3):225-31. doi: 10.1016/0022-3956(84)90013-x. [PMID: 6149317]
  • J A Yesavage, C A Holman, R Cohn, L Lombrozo. Correlation of initial thiothixene serum levels and clinical response. Comparison of fluorometric, gas chromatographic, and RBC assays. Archives of general psychiatry. 1983 Mar; 40(3):301-4. doi: 10.1001/archpsyc.1983.01790030071009. [PMID: 6830409]
  • T Van Putten, P R May, S R Marder, J N Wilkins, B J Rosenberg. Plasma levels of thiothixene by radioreceptor assay: clinical usefulness. Psychopharmacology. 1983; 79(1):40-4. doi: 10.1007/bf00433014. [PMID: 6403963]
  • S C Bogema, N Narasimhachari, M Mumtaz, S Goldin, R O Friedel. Separation and quantitation of cis- and trans-thiothixene in human plasma by high-performance liquid chromatography. Journal of chromatography. 1982 Dec; 233(?):257-67. doi: 10.1016/s0378-4347(00)81752-1. [PMID: 7161337]
  • J A Yesavage. Inpatient violence and the schizophrenic patient: an inverse correlation between danger-related events and neuroleptic levels. Biological psychiatry. 1982 Nov; 17(11):1331-7. doi: NULL. [PMID: 7150681]
  • S D Ravi, G F Borge, F L Roach. Neuroleptics, laryngeal-pharyngeal dystonia and acute renal failure. The Journal of clinical psychiatry. 1982 Jul; 43(7):300. doi: NULL. [PMID: 7085593]
  • R Moskovitz, C L DeVane, R Harris, R B Stewart. Toxic hepatitis and single daily dosage imipramine therapy. The Journal of clinical psychiatry. 1982 Apr; 43(4):165-6. doi: NULL. [PMID: 7068550]
  • J A Yesavage, J Becker, P D Werner, M J Mills, C A Holman, R Cohn. Serum level monitoring of thiothixene in schizophrenia: acute single-dose levels at fixed doses. The American journal of psychiatry. 1982 Feb; 139(2):174-8. doi: 10.1176/ajp.139.2.174. [PMID: 7055286]
  • B V Reifler, N Ward, C M Davis, R O Freidel. Thiothixene plasma levels and clinical response in acute schizophrenia. The Journal of clinical psychiatry. 1981 May; 42(5):207-11. doi: NULL. [PMID: 7217026]
  • J A Yesavage, C A Holman, R Cohn. Correlation of thiothixene serum levels and age. Psychopharmacology. 1981; 74(2):170-2. doi: 10.1007/bf00432687. [PMID: 6791222]
  • L E Tune, I Creese, J R DePaulo, P R Slavney, S H Snyder. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients. The Journal of nervous and mental disease. 1981 Jan; 169(1):60-3. doi: 10.1097/00005053-198101000-00009. [PMID: 6108981]
  • F A Wiesel, L Bjerkenstedt, P Skett. Effect of melperone, two of its metabolites and thiothixene on central monoamine metabolism and prolactin levels in rodents. Acta pharmacologica et toxicologica. 1978 Aug; 43(2):129-36. doi: 10.1111/j.1600-0773.1978.tb02246.x. [PMID: 696342]
  • J P Davy, M Moulin, J C Andersson, J J Halbecq, P Morel, E Poilpre. [Relations between the levels of neuroleptics and the doses, the therapeutic effects and the side effects]. L'Encephale. 1978; 4(4):293-321. doi: NULL. [PMID: 33791]
  • T B Cooper. Plasma level monitoring of antipsychotic drugs. Clinical pharmacokinetics. 1978 Jan; 3(1):14-38. doi: 10.2165/00003088-197803010-00002. [PMID: 25154]
  • L Bjerkenstedt, P Eneroth, C Härnryd, G Sedvall. Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women. Archiv fur Psychiatrie und Nervenkrankheiten. 1977 Dec; 224(4):281-93. doi: 10.1007/bf00341611. [PMID: 343747]
  • G d'Elia, L Jacobsson, L von Knorring, B Mattsson, T Mjörndal, L Oreland, C Perris, W Rapp. Changes in psychopathology in relation to EEG variables and visual averaged evoked responses (V.AER) in schizophrenic patients treated with penfluridol or thiothixene. Acta psychiatrica Scandinavica. 1977 Apr; 55(4):309-18. doi: 10.1111/j.1600-0447.1977.tb00175.x. [PMID: 855677]
  • P A Bombardt, R O Friedel. A GC/CIMS assay for the cis and trans isomers of thiothixene in human plasma. Communications in psychopharmacology. 1977; 1(1):49-59. doi: NULL. [PMID: 606472]
  • C Carlsson, S J Dencker, G Grimby, J Häggendal, G Johnsson. Hemodynamic effects of thiothixene and chlorpromazine in schizophrenic patients at rest and during exercise. International journal of clinical pharmacology and biopharmacy. 1976 Jun; 13(4):262-8. doi: NULL. [PMID: 965133]
  • L Jacobsson, L von Knorring, B Mattsson, T Mjörndal, L Oreland, C Perris, W Rapp, B Edenius, B Kettner, K E Magnusson, P Villemoes. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology. International pharmacopsychiatry. 1976; 11(4):206-14. doi: NULL. [PMID: 795779]
  • H E Himwich. Summary of symposium. Biological psychiatry. 1975 Aug; 10(4):453-8. doi: NULL. [PMID: 240450]
  • R Bergling, T Mjorndal, L Oreland, W Rapp, S Wold. Plasma levels and clinical effects of thioridazine and thiothixene. Journal of clinical pharmacology. 1975 Feb; 15(2-3):178-86. doi: 10.1002/j.1552-4604.1975.tb02354.x. [PMID: 1091665]
  • T Mjörndal, L Oreland. Determination of thioxanthenes in plasma at therapeutic concentrations. Acta pharmacologica et toxicologica. 1971; 29(4):295-302. doi: 10.1111/j.1600-0773.1971.tb00591.x. [PMID: 5109978]